| The human paraoxonase‐1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters HZ Mirdamadi, F Sztanek, Z Derdak, I Seres, M Harangi, G Paragh British journal of clinical pharmacology 66 (3), 366-374, 2008 | 81 | 2008 |
| Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease F Sztanek, I Seres, M Harangi, L Lőcsey, J Padra, GJR Paragh, L Asztalos, ... Nephrology Dialysis Transplantation 27 (7), 2866-2872, 2012 | 55 | 2012 |
| Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity M Harangi, HZ Mirdamadi, I Seres, F Sztanek, M Molnár, A Kassai, ... Translational Research 153 (4), 190-198, 2009 | 51 | 2009 |
| Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels I Seres, L Bajnok, M Harangi, F Sztanek, P Koncsos, G Paragh Paraoxonases in Inflammation, Infection, and Toxicology, 129-142, 2010 | 47 | 2010 |
| Az oxidatív stressz szerepe a diabeteses neuropathia kialakulásában| The role of oxidative stress in the development of diabetic neuropathy F Sztanek, Á Molnárné Molnár, Z Balogh Orvosi hetilap 157 (49), 1939-1946, 2016 | 33 | 2016 |
| Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients E Varga, I Seres, M Harangi, F Sztanek, L Asztalos, L Lõcsey, B Borbás, ... Disease Markers 26 (3), 141-148, 2009 | 23 | 2009 |
| Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy B Nádró, H Lőrincz, Á Molnár, A Szentpéteri, E Zöld, I Seres, D Páll, ... Journal of International Medical Research 49 (5), 03000605211012213, 2021 | 19 | 2021 |
| A diabeteses cardialis autonóm neuropathia diagnosztikája= Diagnosis of diabetic cardiac autonomic neuropathy F Sztanek, É Jebelovszki, B Gaszner, M Zrínyi, D Páll, P Kempler, ... Orvosi Hetilap 160 (35), 1366-1375, 2019 | 17 | 2019 |
| Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease F Sztanek, I Seres, M Harangi, L Lőcsey, P Koncsos, G Paragh Kidney and Blood Pressure Research 36 (1), 310-319, 2013 | 17 | 2013 |
| Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients L Locsey, I Seres, F Sztanek, M Harangi, J Padra, D Kovacs, R Fedor, ... Transplantation proceedings 45 (10), 3685-3687, 2013 | 17 | 2013 |
| Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure É Varga, I Seres, M Harangi, I Kárpáti, P Koncsos, F Sztanek, G Paragh Kidney and Blood Pressure Research 35 (4), 265-272, 2012 | 12 | 2012 |
| Determination of serum progranulin in patients with untreated familial hypercholesterolemia B Nádró, H Lőrincz, L Juhász, A Szentpéteri, F Sztanek, É Varga, D Páll, ... Biomedicines 10 (4), 771, 2022 | 7 | 2022 |
| Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with diabetic neuropathy F Sztanek, I Seres, H Lorincz, A Molnar, G Paragh Atherosclerosis 263, e263, 2017 | 7 | 2017 |
| Change of fibroblast growth factor 21 level correlates with the severity of diabetic sensory polyneuropathy after six-week physical activity Á Molnár, A Szentpéteri, H Lőrincz, I Seres, M Harangi, Z Balogh, ... Reviews in Cardiovascular Medicine 23 (5), 160, 2022 | 4 | 2022 |
| New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists F Sztanek, LI Tóth, A Pető, M Hernyák, Á Diószegi, M Harangi Biomedicines 12 (6), 1320, 2024 | 3 | 2024 |
| Gender-dependent associations between Serum Betatrophin levels and Lipoprotein subfractions in diabetic and nondiabetic obese patients H Lőrincz, S Csiha, B Ratku, S Somodi, F Sztanek, I Seres, G Paragh, ... International Journal of Molecular Sciences 24 (22), 16504, 2023 | 3 | 2023 |
| Diabetic neuropathy and other diabetic complications at the Diabetic Neuropathy Center of the University of Debrecen F Sztanek, B Balogh, Á Molnár, E Zöld, N Tóth, AÁ Jakab, G Paragh Orvosi Hetilap 161 (30), 1243-1251, 2020 | 3 | 2020 |
| The effect of α-lipoic acid treatment on plasma asymmetric dimethylarginine, a biomarker of endothelial dysfunction in diabetic neuropathy F Sztanek, H Lőrincz, Á Molnár, A Szentpéteri, E Zöld, I Seres, D Páll, ... Archives of Medical Science, 2020 | 3 | 2020 |
| A diabeteses neuropathia és az irizin hormon változása fizikai aktivitás hatására 2-es típusú cukorbetegségben. F Sztanek, V Kiss, Eszter, A Molnár, I Seres, H Lőrincz, G Paragh, ... Diabetologia Hungarica 24 (3.), 189-197., 2016 | 3 | 2016 |
| A diabeteses neuropathia és egyéb szövődmények előfordulása a Debreceni Egyetem Diabeteses Neuropathia Centrumában F Sztanek, B Balogh, Á Molnár, E Zöld, N Tóth, AÁ Jakab, G Paragh Orvosi Hetilap 161 (30), 1243-1251, 2020 | 2 | 2020 |
